Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 10 Apr 23 424B3 Prospectus supplement
- 10 Apr 23 EFFECT Notice of effectiveness
- 4 Apr 23 POS AM Prospectus update (post-effective amendment)
- 30 Jan 23 424B3 Prospectus supplement
- 12 Sep 22 EFFECT Notice of effectiveness
- 9 Sep 22 424B3 Prospectus supplement
-
1 Sep 22 S-1/A IPO registration (amended)
- 12 Aug 22 S-1 IPO registration
APGN similar filings
Filing view
External links
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the use in this Amendment No.1 to Registration Statement on Form S-1 (No. 333-266847) of Apexigen, Inc. of our report dated April 8, 2022, relating to the financial statements of Apexigen, Inc. as of December 31, 2021 and 2020, and for the years then ended (which report expresses an unqualified opinion and includes an explanatory paragraph relating to a going concern uncertainty). We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ Moss Adams LLP
San Francisco, California
September 1, 2022